Anchored Launches US Tokenized Stocks to Expand Global Investor Access
16.4.2026 13:00:00 CEST | Business Wire | Press Release
Anchored, the global digital operating system for real-world assets, today announced the launch of its first product, tokenized US stocks on Monad's high-performance Layer 1 network, starting with the top 10 Nasdaq-listed equities via its Monday Trade integration. The launch is powered by Alpaca, a leading global provider of brokerage infrastructure APIs and an infrastructure layer supporting tokenized stocks, offering access to options, stocks, ETFs, fixed income, and crypto.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260416940316/en/
Anchored Launches US Tokenized Stocks to Expand Global Investor Access
The total value of tokenized US equities has grown nearly 300% since early 2025, with Alpaca as the leading infrastructure powering them*. This growth highlights a critical shift in how global markets manage and trade value.
Anchored provides end-to-end infrastructure for the full capital formation lifecycle: origination, compliance, issuance, distribution across both DeFi and centralized platforms, secondary market liquidity, and redemption. Tokenized US equities represent the platform's first product vertical, offering 1:1 asset backing, real-time price alignment with underlying markets, and institutional-grade compliance infrastructure.
With its platform, Anchored purchases the underlying US equities, tokenizes them, and issues fully backed on-chain representations, leveraging the partnership with Alpaca while reducing the need for intermediaries. This brings the transparency, instant settlement, and operational efficiency of blockchain technology to traditional equities under a compliance-first framework, ensuring institutional partners and investors operate within a fully regulated environment.
- Powered by Alpaca’s Broker API, Anchored’s tokenized US stock product offers several key features:
- Expansive Asset List: Investors gain access to the top 10 US Nasdaq stocks by market cap, with plans to exceed 100 tokenized stocks in the coming months
- 24/7 Transferability: Assets that can be transferred peer-to-peer anytime and anywhere, eliminating the constraints of traditional market hours
- Institutional-Grade Liquidity: Liquidity access comparable to traditional exchanges, ensuring execution for their investors
- Full Collateralization: Every tokenized stock is 1:1 backed by actual US stocks
- DeFi Composability: Tokenized assets that are programmable and usable across DeFi protocols, unlocking new capital efficiency opportunities
- Stablecoin Funding: The system uses USDC deposits and withdrawals for daily settlement
"Capital formation is moving on-chain, and the infrastructure needs to be institutional-grade from day one. The current financial system relies on infrastructure that was not built for a digital-first world,” said Wenny Cai, Co-Founder and CEO of Anchored. “With Anchored, investors can access fully backed tokenized US stocks through their existing digital asset infrastructure while trading 24/7, settling instantly, and deploying these assets programmatically within DeFi. The opportunity we're building for is the full picture spanning US equities, Hong Kong equities, and institutional fund products in one stack, distributed to the investors who need access to them most.”
"The global financial system is undergoing a massive shift from the simple computerized infrastructure to on-chain systems,” said Yoshi Yokokawa, Co-Founder and CEO of Alpaca. “We are moving toward a future defined by atomic settlement, real-time transparency, and structurally reduced systemic risk. Through our collaboration with partners like Anchored, we’re proud to support institutions leading this transition to on-chain infrastructure while expanding global market access.”
This launch marks the first milestone in Anchored's mission to build end-to-end infrastructure for RWA issuance, distribution, and trading with Hong Kong equities, ETFs, and tokenized fund products to follow.
About Alpaca
Alpaca is a US-headquartered, self-clearing broker-dealer and a global leader in brokerage infrastructure APIs providing access to stocks, ETFs, options, fixed income, and crypto. Alpaca delivers embeddable finance solutions for tokenization, fully paid securities lending, high-yield cash, 24/5 trading, Shariah-compliant investing, and more. Today, Alpaca powers over 10 million brokerage accounts across hundreds of fintechs and institutions in 40+ countries with over $320M in funding. For more information, visit: alpaca.markets
About Anchored
Anchored is the global digital operating system for real-world assets, providing the end-to-end infrastructure for tokenizing, distributing, and trading real-world assets on-chain. The platform supports the full asset lifecycle, from origination and compliance through issuance, distribution across DeFi and CeFi, secondary market liquidity, and redemption. Operating under a compliance-first, globally scalable architecture, Anchored serves institutional investors, market makers, and DeFi protocols seeking on-chain access to public equities and fund products. For more information, visit https://anchored.finance/
*As of April 2026
Alpaca's Instant Tokenization Network is owned and developed by AlpacaDB, Inc. and Alpaca Crypto LLC.
Additional geographic restrictions may apply for tokenization services based on local regulatory requirements. Neither Alpaca Crypto LLC nor Alpaca Securities LLC (dba Alpaca Clearing) are the issuer of, nor directly involved in, the tokenization of any assets. Tokenization is performed by a third party. Tokenized assets do not represent direct equity ownership in any underlying company or issuer. Instead, tokenized assets generally provide economic exposure to the equity securities of an underlying issuer. As such, holders of tokenized assets have no voting rights, dividend entitlements, or legal claims to the underlying company shares or any residual assets in the event of the underlying company’s liquidation or insolvency, unless explicitly stated otherwise. All investments involve risk. For more information, please see our Tokenization Risk Disclosure.
AlpacaDB, Inc., the parent company of Alpaca Securities LLC and Alpaca Crypto LLC, provides services and technology, including the brokerage infrastructure API supporting Alpaca’s financial services.
Securities brokerage services are provided by Alpaca Securities LLC (dba “Alpaca Clearing”), member FINRA/SIPC, a wholly owned subsidiary of AlpacaDB, Inc.
Cryptocurrency services are provided by Alpaca Crypto LLC, a FinCEN-registered MSB (NMLS #2160858) and subsidiary of AlpacaDB, Inc.
This is not an offer, solicitation of an offer, or advice to buy or sell securities or cryptocurrencies or open a brokerage account or cryptocurrency account in any jurisdiction where Alpaca Securities or Alpaca Crypto, respectively, are not registered or licensed, as applicable.
All investments involve risk; for more information, please see our Disclosure Library.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260416940316/en/
Contacts
Media Contact
Lavinia Chirico
press@alpaca.markets
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AACR 2026: Crown Bioscience Showcases Integrated Platforms Enabling Next-Generation Oncology Modalities, Including ADCs and Radiopharmaceuticals16.4.2026 14:30:00 CEST | Press Release
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced it will present new data at the AACR Annual Meeting 2026 demonstrating how integrated, patient-derived platforms can accelerate the development of complex oncology modalities, including antibody-drug conjugates (ADCs) and radiopharmaceuticals. Across 12 poster presentations, the company highlights scalable approaches to improve target selection, optimize payload design, and overcome resistance, addressing key challenges in translational oncology. Collectively, the data underscore the need for predictive, clinically relevant models that better reflect tumor biology and treatment response. By combining patient-derived xenografts (PDX), 3D tumor organoid models, multi-omics, and imaging approaches, Crown Bioscience demonstrates how integrated workflows support more informed decision-making earlier in development, particularly as the industry advances increasingly complex therap
AACR 2026: Crown Bioscience Showcases Integrated Platforms Enabling Next-Generation Oncology Modalities, Including ADCs and Radiopharmaceuticals16.4.2026 14:30:00 CEST | Press Release
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced it will present new data at the AACR Annual Meeting 2026 demonstrating how integrated, patient-derived platforms can accelerate the development of complex oncology modalities, including antibody-drug conjugates (ADCs) and radiopharmaceuticals. Across 12 poster presentations, the company highlights scalable approaches to improve target selection, optimize payload design, and overcome resistance, addressing key challenges in translational oncology. Collectively, the data underscore the need for predictive, clinically relevant models that better reflect tumor biology and treatment response. By combining patient-derived xenografts (PDX), 3D tumor organoid models, multi-omics, and imaging approaches, Crown Bioscience demonstrates how integrated workflows support more informed decision-making earlier in development, particularly as the industry advances increasingly complex therap
Waiv Achieves Dual CE Marking Under IVDR, Propelling AI Precision Testing for Breast and Colorectal Cancer for Clinical Routine16.4.2026 14:00:00 CEST | Press Release
Waiv, formerly Owkin Dx, a company advancing AI precision testing, today announced that two of its AI precision tests, RlapsRisk® BC for breast cancer prognostic risk profiling and MSIntuit® CRC for colorectal cancer MSI screening, have each received CE marking under the European In Vitro Diagnostic Regulation (IVDR), authorising clinical deployment across EU member states. Improving Patient Outcomes Through AI-Driven Precision Testing RlapsRisk BC predicts breast cancer relapse risk directly from standard histopathology slides, and has the potential to deliver genomic-level risk profiling insights to any pathology lab, without extensive further testing. By identifying high-risk patients earlier, it enables more informed, personalized treatment decisions, helping clinicians target aggressive therapies where needed while sparing lower-risk patients from unnecessary treatment. MSIntuit CRC applies an AI-enabled precision approach to colorectal cancer by offering rapid, scalable Microsate
Waiv Achieves Dual CE Marking Under IVDR, Propelling AI Precision Testing for Breast and Colorectal Cancer for Clinical Routine16.4.2026 14:00:00 CEST | Press Release
Waiv, formerly Owkin Dx, a company advancing AI precision testing, today announced that two of its AI precision tests, RlapsRisk® BC for breast cancer prognostic risk profiling and MSIntuit® CRC for colorectal cancer MSI screening, have each received CE marking under the European In Vitro Diagnostic Regulation (IVDR), authorising clinical deployment across EU member states. Improving Patient Outcomes Through AI-Driven Precision Testing RlapsRisk BC predicts breast cancer relapse risk directly from standard histopathology slides, and has the potential to deliver genomic-level risk profiling insights to any pathology lab, without extensive further testing. By identifying high-risk patients earlier, it enables more informed, personalized treatment decisions, helping clinicians target aggressive therapies where needed while sparing lower-risk patients from unnecessary treatment. MSIntuit CRC applies an AI-enabled precision approach to colorectal cancer by offering rapid, scalable Microsate
NetApp Collaborates with Google Cloud to Power Data Infrastructure for Distributed Cloud16.4.2026 14:00:00 CEST | Press Release
NetApp® (NASDAQ: NTAP), the Intelligent Data Infrastructure company, today announced that it has expanded its collaboration with Google Cloud with a 4-year Enterprise Agreement to accelerate the deployment of the NetApp storage solutions within the Google Distributed Cloud air-gapped (GDC), Google's sovereign cloud platform delivered by World Wide Technology (WWT). The NetApp data platform within this full-stack, air-gapped private cloud solution delivers the built-in security organizations need to handle sensitive information and meet data sovereignty requirements. “For government agencies and defense organizations, sensitive and classified data can’t leave controlled environments, but that data is also critical to AI‑driven decision‑making,” said Cesar Cernuda, President at NetApp. “By embedding NetApp’s secure-by-design storage systems into Google Distributed Cloud, we're enabling customers to build Intelligent Data Infrastructure that provides the foundation to support accredited,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom